Endogenous FGF21 attenuates blood-brain barrier disruption in penumbra after delayed recanalization in MCAO rats through FGFR1/PI3K/Akt pathway.
10.11817/j.issn.1672-7347.2023.220380
- Author:
Wen ZHENG
1
;
Wenjun LI
2
;
Yini ZENG
2
;
Hui YUAN
2
;
Heng YANG
2
;
Ru CHEN
2
;
Anding ZHU
2
;
Jinze WU
2
;
Zhi SONG
2
;
Wenguang YAN
3
Author Information
1. Department of Neurology, Third Xiangya Hospital, Central South University, Changsha 410013. zhengwen5309@163.com.
2. Department of Neurology, Third Xiangya Hospital, Central South University, Changsha 410013.
3. Department of Rihabilitation Medicine, Third Xiangya Hospital, Central South University, Changsha 410013, China. 2402632247@qq.com.
- Publication Type:Journal Article
- Keywords:
blood-brain barrier disruption;
delayed recanalization;
fibroblast growth factor 21;
ischemia/reperfusion injury;
middle cerebral artery occlusion
- MeSH:
Animals;
Rats;
Blood-Brain Barrier/metabolism*;
Brain Ischemia;
Claudin-5/metabolism*;
Infarction, Middle Cerebral Artery/metabolism*;
Ischemic Stroke/metabolism*;
Occludin/metabolism*;
Phosphatidylinositol 3-Kinases/metabolism*;
Proto-Oncogene Proteins c-akt/metabolism*;
Rats, Sprague-Dawley;
Receptor, Fibroblast Growth Factor, Type 1/metabolism*;
Reperfusion Injury/metabolism*
- From:
Journal of Central South University(Medical Sciences)
2023;48(5):648-662
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Restoration of blood circulation within "time window" is the principal treating goal for treating acute ischemic stroke. Previous studies revealed that delayed recanalization might cause serious ischemia/reperfusion injury. However, plenty of evidences showed delayed recanalization improved neurological outcomes in acute ischemic stroke. This study aims to explore the role of delayed recanalization on blood-brain barrier (BBB) in the penumbra (surrounding ischemic core) and neurological outcomes after middle cerebral artery occlusion (MCAO).
METHODS:Recanalization was performed on the 3rd day after MCAO. BBB disruption was tested by Western blotting, Evans blue dye, and immunofluorescence staining. Infarct volume and neurological outcomes were evaluated on the 7th day after MCAO. The expression of fibroblast growth factor 21 (FGF21), fibroblast growth factor receptor 1 (FGFR1), phosphatidylinositol-3-kinase (PI3K), and serine/threonine kinase (Akt) in the penumbra were observed by immunofluorescence staining and/or Western blotting.
RESULTS:The extraversion of Evans blue, IgG, and albumin increased surrounding ischemic core after MCAO, but significantly decreased after recanalization. The expression of Claudin-5, Occludin, and zona occludens 1 (ZO-1) decreased surrounding ischemic core after MCAO, but significantly increased after recanalization. Infarct volume reduced and neurological outcomes improved following recanalization (on the 7th day after MCAO). The expressions of Claudin-5, Occludin, and ZO-1 decreased surrounding ischemic core following MCAO, which were up-regulated corresponding to the increases of FGF21, p-FGFR1, PI3K, and p-Akt after recanalization. Intra-cerebroventricular injection of FGFR1 inhibitor SU5402 down-regulated the expression of PI3K, p-Akt, Occludin, Claudin-5, and ZO-1 in the penumbra, which weakened the beneficial effects of recanalization on neurological outcomes after MCAO.
CONCLUSIONS:Delayed recanalization on the 3rd day after MCAO increases endogenous FGF21 in the penumbra and activates FGFR1/PI3K/Akt pathway, which attenuates BBB disruption in the penumbra and improves neurobehavior in MCAO rats.
